Electronic Vaccine Intelligence Network to follow COVID-19 antibody Kumar Jeetendra | September 21, 2020 The Electronic Vaccine Intelligence Network (eVIN) system, which provides real-time information on vaccine stocks and storage temperatures across all cold chain points in the nation, has been enhanced to deal with the needs for distribution and tracking of COVID-19 vaccine, whenever it becomes available, the Rajya Sabha was informed on September 20. A national expert …
Chikungunya: The silent vector borne co-infection in Monsoon season Kumar Jeetendra | September 20, 2020 The prevalence of fever and joint pain is so common of symptoms that it overlaps with almost any prevalent disease in the tropics and hence for the better part of the virulent pathway of CHIK virus in the body, the patients remain asymptomatic to the detection of Chikungunya, thereby making it more life-threatening and requiring …
New polygenic danger score to help foresee the chances of medications causing liver harm Kumar Jeetendra | September 20, 2020 The ancient Romans studied the livers of sacrificial animals to read omens and create prophesies. Researchers at Tokyo Medical and Dental University (TMDU) and Takeda-CiRA program alongside a world-wide group of collaborators, have devised a polygenic risk score (PRS) based on liver genomics that can predict the probability of medications causing liver damage. Adding new …
Study recommends e-cigarettes are adding to diminish smoking pervasiveness Kumar Jeetendra | September 19, 2020 Individuals who smoke are using e-cigarettes to try to give up smoking, a study by researchers at the University of Otago, Wellington, has discovered. The researchers found that between 2016 and 2018 the level of awareness, as well as the use of e-cigarettes, increased among smokers and those who had recently quit smoking. The principal …
Key China COVID-19 examination delivered results that affected ensuing exploration on Covid Kumar Jeetendra | September 18, 2020 Crucial China COVID-19 study produced results that Affected subsequent research on coronavirus Early in the start of the COVID-19 pandemic, a small study in China produced results that affected subsequent research on the virus. Researchers at the University of Cincinnati used the same research parameters on a much larger patient population and reached completely different …
Effect of Discreet Monsoon on Dengue Epidemiology Kumar Jeetendra | September 17, 2020 The arrival Mosquitoes and Dengue with the seasonal rains are pivotal in understanding the pathogenesis of the virus in tropical medicine. Dengue has been a resonant feature in the Indian subcontinent making epidemic outbreaks in the last 4 decades, but it was in the last decade that the diagnosis of the virus took the impetus …
US intends to convey COVID-19 immunization following approval Kumar Jeetendra | September 16, 2020 The US government plans to start distributing a COVID-19 vaccine within one day of any regulatory authorization, an official from the research said on September 16. Government officials also said the US Centers for Disease Control and Prevention will decide how initial, limited vaccine doses will be allocated and distributed.
A few immunosuppressants don’t build COVID-19 risk: Scientists Kumar Jeetendra | September 15, 2020 Therapeutics which suppress the immune system in people who have inflammatory diseases like psoriasis and rheumatoid arthritis”are not associated with a significantly greater risk” for contracting COVID-19, according to a study which says these patients should continue taking their medicine as prescribed. Dermatology researchers in the Henry Ford Health System in the US, which treats …
PC planned antiviral proteins restrain COVID-19 in lab, researchers find Kumar Jeetendra | September 14, 2020 Computer-designed synthetic antiviral proteins have been shown to protect lab-grown human cells from SARS-CoV-2, the coronavirus that causes COVID-19, scientists say. From the experiments, the lead antiviral candidate, called LCB1, rivalled the best-known SARS-CoV-2 neutralising antibodies in its protective activities, according to the findings published in the journal Science. The researchers at the University of …
Asia offers more influenza shots to take off COVID-19 difficulties Kumar Jeetendra | September 14, 2020 Some Asian countries are rolling out early and more competitive influenza vaccination programs this year, seeking to decrease the capacity of people contracting the flu and COVID-19 simultaneously, crippling health care systems. With a second or third wave of the coronavirus pandemic looming for many countries, tackling this year’s flu season – typically December through …
DCGI orders Serum Institute of India to suspend enrollment for Oxford COVID-19 immunization preliminaries Kumar Jeetendra | September 12, 2020 Drugs Controller General of India (DCGI) has led Serum Institute of India to suspend until further orders new recruitment in stage 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in different countries. In an order, a copy of which was obtained by …
Bharat Biotech States Covaxin generated Strong immune response in monkeys Kumar Jeetendra | September 12, 2020 Bharat Biotech announced its prospective COVID-19 vaccine — Covaxin — was discovered to generate strong immune responses in rhesus macaques or monkeys, preventing infection and disease even upon high levels of exposure to live SARS-CoV-2 virus. The Hyderabad-based firm said data from the study on primates substantiate the immunogenicity of the vaccine candidate. Covaxin developed …
